Kelly Collins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kelly Collins has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Shunji Nagai
Division of Transplant Surgery, Henry Ford Hospital, Detroit, USA
7 shared publications - Toshihiro Kitajima
Division of Transplant and Hepatobiliary Surgery, Henry Ford Health System, Detroit, USA
6 shared publications Atsushi Yoshida
Division of Transplant and Hepatobiliary Surgery, Henry Ford Health System, Detroit, USA
5 shared publications- Marwan Abouljoud
Division of Transplant Surgery, Henry Ford Hospital, Detroit, USA
5 shared publications Michael Rizzari
Division of Transplant and Hepatobiliary Surgery, Henry Ford Health System, Detroit, USA
5 shared publications- Tommy Ivanics
Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada
5 shared publications
Latest Publications
- 10 December 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1422-1423
ASO Visual Abstract: Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients With Hepatocellular Carcinoma
- 10 December 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1422-1423
ASO Visual Abstract: Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients With Hepatocellular Carcinoma
- 25 November 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1408-1419
Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma
Liver transplant (LT) candidates with hepatocellular carcinoma (HCC) often receive cancer treatment before transplant. We investigated the impact of pre-tr
- 25 November 2022
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (3) , 1408-1419
Multiple Pretransplant Treatments for Patients Without Pathological Complete Response may Worsen Posttransplant Outcomes in Patients with Hepatocellular Carcinoma
Liver transplant (LT) candidates with hepatocellular carcinoma (HCC) often receive cancer treatment before transplant. We investigated the impact of pre-tr
- Open Access
- 5 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (9) , 2261-2264
The use of normothermic liver preservation in combined liver and lung transplantation: A single-center experience
- 5 April 2022
- Published by Elsevier in American Journal of Transplantation
- Vol. 22 (9) , 2261-2264
Open AccessThe use of normothermic liver preservation in combined liver and lung transplantation: A single-center experience
- 27 May 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (11) , 1563-1576
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver‐Kidney Allocation Policy
The Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) policy regarding kidney allocation for liver transplantation (LT) patients was implemented in August 2017. This study evaluated the effects of the simultaneous liver‐kidney transplantation (SLKT) policy on outcomes in LT alone (LTA) patients with kidney dysfunction. We analyzed adult primary LTA patients with kidney dysfunction at listing (estimated glomerular filtration rate [eGFR] less than 30 mL/minute or dialysis requirement) between January 2015 and March 2019 using the OPTN/UNOS registry. Waitlist practice and kidney transplantation (KT) listing after LTA were compared between prepolicy and postpolicy groups. There were 3821 LTA listings with eGFR P < 0.001). Of these LTA listings, 90‐day LT waitlist mortality, LTA probability, and 1‐year post‐LTA survival were similar between eras. LTA recipients in Era 2 had a higher probability for KT listing after LTA than those in Era 1 (6.2% versus 3.9%; odds ratio [OR], 3.30; P < 0.001), especially those on dialysis (8.4% versus 2.0%; OR, 4.38; P < 0.001). Under the safety net rule, there was a higher KT probability after LTA (26.7% and 53% at 6 months in Eras 1 and 2, respectively; P = 0.02). After the implementation of the policy, the number of LTA listings among patients on dialysis increased significantly. While their posttransplant survival did not change, KT listing after LTA increased. The safety net rule led to high KT probability and a low waitlist mortality rate in patients who were listed for KT after LTA. These results suggest that the policy successfully achieved the goals of providing appropriate opportunities of KT for LT patients, which did not compromise LTA waitlist or posttransplant outcomes in patients with kidney dysfunction and provided KT opportunities if patients developed kidney failure after LTA.
- 27 May 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (11) , 1563-1576
Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver‐Kidney Allocation Policy
The Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS) policy regarding kidney allocation for liver transplantation (LT) patients was implemented in August 2017. This study evaluated the effects of the simultaneous liver‐kidney transplantation (SLKT) policy on outcomes in LT alone (LTA) patients with kidney dysfunction. We analyzed adult primary LTA patients with kidney dysfunction at listing (estimated glomerular filtration rate [eGFR] less than 30 mL/minute or dialysis requirement) between January 2015 and March 2019 using the OPTN/UNOS registry. Waitlist practice and kidney transplantation (KT) listing after LTA were compared between prepolicy and postpolicy groups. There were 3821 LTA listings with eGFR P < 0.001). Of these LTA listings, 90‐day LT waitlist mortality, LTA probability, and 1‐year post‐LTA survival were similar between eras. LTA recipients in Era 2 had a higher probability for KT listing after LTA than those in Era 1 (6.2% versus 3.9%; odds ratio [OR], 3.30; P < 0.001), especially those on dialysis (8.4% versus 2.0%; OR, 4.38; P < 0.001). Under the safety net rule, there was a higher KT probability after LTA (26.7% and 53% at 6 months in Eras 1 and 2, respectively; P = 0.02). After the implementation of the policy, the number of LTA listings among patients on dialysis increased significantly. While their posttransplant survival did not change, KT listing after LTA increased. The safety net rule led to high KT probability and a low waitlist mortality rate in patients who were listed for KT after LTA. These results suggest that the policy successfully achieved the goals of providing appropriate opportunities of KT for LT patients, which did not compromise LTA waitlist or posttransplant outcomes in patients with kidney dysfunction and provided KT opportunities if patients developed kidney failure after LTA.
- 25 January 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (7) , 971-983
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30
Although recent studies have reported favorable outcomes in living donor liver transplantation (LDLT), it remains unclear which populations benefit most from LDLT. This study aims to evaluate LDLT outcomes compared with deceased donor LT (DDLT) according to Model for End‐Stage Liver Disease (MELD) score categories. Using data from the United Network for Organ Sharing registry, outcomes were compared between 1486 LDLTs; 13,568 donation after brain death (DBD)‐DDLTs; and 1171 donation after circulatory death (DCD)‐DDLTs between 2009 and 2018. Because LDLT for patients with MELD scores >30 was rare, all patients with scores >30 were excluded to equalize LDLT and DDLT cohorts. Risk factors for 1‐year graft loss (GL) were determined separately for LDLT and DDLT. Compared with LDLT, DBD‐DDLT had a lower risk of 30‐day (adjusted hazard ratio [aHR], 0.60; P < 0.001) and 1‐year GL (aHR, 0.57; P < 0.001). The lower risk of GL was more prominent in the mid‐MELD score category (score 15‐29). Compared with LDLT, DCD‐DDLT had a lower risk of 30‐day GL but a comparable risk of 1‐year GL, regardless of MELD score category. In LDLT, significant ascites was an independent risk for GL in patients with mid‐MELD scores (aHR, 1.68; P = 0.02), but not in the lower‐MELD score group. The risk of 1‐year GL in LDLT patients with ascites who received a left liver was higher than either those who received a right liver or those without ascites who received a left liver. In LDLT, combinations of MELD scores of 15 to 29, moderate/severe ascites, and the use of a left liver are associated with worse outcomes. These findings help calibrate appropriate patient and graft selection in LDLT.
- 25 January 2021
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 27 (7) , 971-983
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30
Although recent studies have reported favorable outcomes in living donor liver transplantation (LDLT), it remains unclear which populations benefit most from LDLT. This study aims to evaluate LDLT outcomes compared with deceased donor LT (DDLT) according to Model for End‐Stage Liver Disease (MELD) score categories. Using data from the United Network for Organ Sharing registry, outcomes were compared between 1486 LDLTs; 13,568 donation after brain death (DBD)‐DDLTs; and 1171 donation after circulatory death (DCD)‐DDLTs between 2009 and 2018. Because LDLT for patients with MELD scores >30 was rare, all patients with scores >30 were excluded to equalize LDLT and DDLT cohorts. Risk factors for 1‐year graft loss (GL) were determined separately for LDLT and DDLT. Compared with LDLT, DBD‐DDLT had a lower risk of 30‐day (adjusted hazard ratio [aHR], 0.60; P < 0.001) and 1‐year GL (aHR, 0.57; P < 0.001). The lower risk of GL was more prominent in the mid‐MELD score category (score 15‐29). Compared with LDLT, DCD‐DDLT had a lower risk of 30‐day GL but a comparable risk of 1‐year GL, regardless of MELD score category. In LDLT, significant ascites was an independent risk for GL in patients with mid‐MELD scores (aHR, 1.68; P = 0.02), but not in the lower‐MELD score group. The risk of 1‐year GL in LDLT patients with ascites who received a left liver was higher than either those who received a right liver or those without ascites who received a left liver. In LDLT, combinations of MELD scores of 15 to 29, moderate/severe ascites, and the use of a left liver are associated with worse outcomes. These findings help calibrate appropriate patient and graft selection in LDLT.
- Open Access
- 1 November 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3263-3264
Revisiting the organ procurement organization–based organ procurement center in the COVID era
- 1 November 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (11) , 3263-3264
Open AccessRevisiting the organ procurement organization–based organ procurement center in the COVID era
- Open Access
- 14 August 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (3) , 1100-1112
Retransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction
- 14 August 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (3) , 1100-1112
Open AccessRetransplantation outcomes for hepatitis C in the United States before and after direct-acting antiviral introduction
- Open Access
- 1 November 2018
- Published by Elsevier in Gastroenterology
- Vol. 155 (5) , 1451-1462.e3
Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes
- 1 November 2018
- Published by Elsevier in Gastroenterology
- Vol. 155 (5) , 1451-1462.e3
Open AccessEffects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease–Sodium Scores on Patient Outcomes